Stocks and Investing
Stocks and Investing
Thu, January 30, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, January 29, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, January 28, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Andrew Peters Maintained (BIIB) at Strong Buy with Increased Target to $415 on, Jan 28th, 2014
Andrew Peters of Deutsche Bank, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $340 to $415 on, Jan 28th, 2014.
Andrew has made no other calls on BIIB in the last 4 months.
There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Andrew
- Christopher Marai of "Nomura" Initiated at Strong Buy and Held Target at $368 on, Wednesday, January 8th, 2014
- Christopher Raymond of "Piper Sandler" Initiated at Buy on, Tuesday, November 26th, 2013
- Evan Seigerman of "Credit Suisse" Maintained at Buy and Held Target at $290 on, Friday, November 22nd, 2013